Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electrocardiography | 110 | 2024 | 6408 | 9.370 |
Why?
|
Electrocardiography, Ambulatory | 42 | 2023 | 582 | 8.260 |
Why?
|
Arrhythmias, Cardiac | 77 | 2024 | 2257 | 7.460 |
Why?
|
Heart Rate | 93 | 2024 | 4207 | 7.390 |
Why?
|
Heart Conduction System | 42 | 2021 | 1008 | 5.800 |
Why?
|
Ventricular Fibrillation | 74 | 2023 | 538 | 5.660 |
Why?
|
Vagus Nerve Stimulation | 11 | 2023 | 228 | 5.270 |
Why?
|
Flecainide | 8 | 2021 | 41 | 5.030 |
Why?
|
Anti-Arrhythmia Agents | 19 | 2023 | 772 | 4.980 |
Why?
|
Death, Sudden, Cardiac | 38 | 2023 | 1567 | 4.270 |
Why?
|
Atrial Fibrillation | 28 | 2024 | 5182 | 4.050 |
Why?
|
Long QT Syndrome | 11 | 2022 | 473 | 3.350 |
Why?
|
Autonomic Nervous System | 26 | 2021 | 707 | 3.250 |
Why?
|
Tachycardia, Ventricular | 19 | 2023 | 1313 | 3.060 |
Why?
|
Acetanilides | 9 | 2014 | 168 | 2.780 |
Why?
|
Epilepsy | 11 | 2023 | 3317 | 2.380 |
Why?
|
Oxazepines | 4 | 2017 | 22 | 2.150 |
Why?
|
Coronary Stenosis | 7 | 2021 | 804 | 2.090 |
Why?
|
Sodium Channel Blockers | 6 | 2017 | 171 | 2.050 |
Why?
|
Exercise Test | 21 | 2019 | 2188 | 2.020 |
Why?
|
Action Potentials | 14 | 2024 | 1835 | 1.990 |
Why?
|
Torsades de Pointes | 5 | 2019 | 78 | 1.980 |
Why?
|
Amiodarone | 5 | 2017 | 216 | 1.960 |
Why?
|
Atrioventricular Node | 5 | 2023 | 180 | 1.930 |
Why?
|
Myocardial Ischemia | 21 | 2021 | 2131 | 1.790 |
Why?
|
Ventricular Function, Left | 14 | 2023 | 3934 | 1.670 |
Why?
|
Swine | 30 | 2021 | 5985 | 1.470 |
Why?
|
Piperazines | 9 | 2014 | 2547 | 1.450 |
Why?
|
Heart Failure | 19 | 2023 | 11879 | 1.420 |
Why?
|
Pericardium | 10 | 2021 | 681 | 1.400 |
Why?
|
Metoprolol | 4 | 2020 | 90 | 1.380 |
Why?
|
Heart Atria | 11 | 2023 | 1362 | 1.370 |
Why?
|
Adrenergic beta-Antagonists | 16 | 2019 | 1241 | 1.210 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2023 | 2143 | 1.200 |
Why?
|
Heart | 37 | 2023 | 4425 | 1.140 |
Why?
|
Benzazepines | 6 | 2018 | 307 | 1.140 |
Why?
|
Electrophysiologic Techniques, Cardiac | 9 | 2016 | 511 | 1.140 |
Why?
|
Atrial Premature Complexes | 2 | 2018 | 17 | 1.140 |
Why?
|
Dogs | 89 | 2019 | 3834 | 1.110 |
Why?
|
Electric Countershock | 8 | 2017 | 534 | 1.100 |
Why?
|
Coronary Circulation | 23 | 2017 | 1602 | 1.070 |
Why?
|
Cardiovascular Agents | 4 | 2017 | 849 | 1.010 |
Why?
|
Triazoles | 3 | 2015 | 902 | 0.990 |
Why?
|
Epilepsies, Partial | 2 | 2022 | 431 | 0.980 |
Why?
|
Myocardial Infarction | 23 | 2023 | 11514 | 0.970 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2021 | 669 | 0.930 |
Why?
|
Defibrillators, Implantable | 11 | 2021 | 1499 | 0.890 |
Why?
|
Risk Assessment | 31 | 2021 | 24299 | 0.870 |
Why?
|
Myocardial Contraction | 18 | 2018 | 1516 | 0.830 |
Why?
|
Brugada Syndrome | 5 | 2014 | 98 | 0.810 |
Why?
|
Vagus Nerve | 24 | 2023 | 458 | 0.760 |
Why?
|
Animals | 159 | 2023 | 168939 | 0.740 |
Why?
|
Heart Diseases | 7 | 2023 | 2817 | 0.690 |
Why?
|
Nitroglycerin | 6 | 2011 | 332 | 0.690 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 1 | 2020 | 30 | 0.680 |
Why?
|
Disease Models, Animal | 24 | 2021 | 18329 | 0.670 |
Why?
|
Sus scrofa | 5 | 2020 | 431 | 0.660 |
Why?
|
Romano-Ward Syndrome | 1 | 2019 | 3 | 0.660 |
Why?
|
Coronary Disease | 40 | 2024 | 5915 | 0.650 |
Why?
|
Humans | 174 | 2024 | 766812 | 0.650 |
Why?
|
Heart Ventricles | 13 | 2023 | 3831 | 0.640 |
Why?
|
Pyridines | 3 | 2015 | 2888 | 0.630 |
Why?
|
Stellate Ganglion | 18 | 2019 | 52 | 0.630 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2021 | 562 | 0.620 |
Why?
|
Biological Clocks | 2 | 2010 | 320 | 0.600 |
Why?
|
Pulmonary Veins | 1 | 2024 | 759 | 0.600 |
Why?
|
Death, Sudden | 10 | 2022 | 301 | 0.590 |
Why?
|
Exercise Tolerance | 3 | 2019 | 845 | 0.590 |
Why?
|
Vasodilation | 4 | 2011 | 968 | 0.570 |
Why?
|
Male | 142 | 2024 | 364154 | 0.570 |
Why?
|
Acute Coronary Syndrome | 5 | 2021 | 2193 | 0.560 |
Why?
|
Baroreflex | 3 | 2015 | 154 | 0.560 |
Why?
|
Arousal | 5 | 2010 | 1174 | 0.540 |
Why?
|
Administration, Inhalation | 5 | 2020 | 1154 | 0.540 |
Why?
|
Sodium Channels | 2 | 2016 | 339 | 0.540 |
Why?
|
Adrenergic Agents | 1 | 2016 | 72 | 0.520 |
Why?
|
Predictive Value of Tests | 12 | 2024 | 15425 | 0.510 |
Why?
|
Reading | 1 | 2019 | 541 | 0.510 |
Why?
|
Catecholamines | 3 | 2016 | 388 | 0.500 |
Why?
|
Sleep, REM | 7 | 2000 | 593 | 0.500 |
Why?
|
Bundle-Branch Block | 4 | 2021 | 280 | 0.500 |
Why?
|
Sleep Stages | 5 | 2009 | 705 | 0.490 |
Why?
|
Stress, Psychological | 24 | 2013 | 4526 | 0.490 |
Why?
|
Anger | 6 | 2001 | 402 | 0.480 |
Why?
|
Seizures | 4 | 2022 | 2996 | 0.470 |
Why?
|
Catheter Ablation | 3 | 2024 | 2787 | 0.470 |
Why?
|
Treatment Outcome | 24 | 2024 | 65286 | 0.460 |
Why?
|
Ventricular Pressure | 1 | 2015 | 210 | 0.460 |
Why?
|
Cardiovascular Diseases | 17 | 2023 | 15652 | 0.450 |
Why?
|
Air Pollutants | 11 | 2005 | 2919 | 0.440 |
Why?
|
Heart Arrest | 2 | 2020 | 1516 | 0.440 |
Why?
|
Stroke Volume | 11 | 2023 | 5618 | 0.430 |
Why?
|
Emotions | 5 | 2010 | 2758 | 0.430 |
Why?
|
Drug Delivery Systems | 3 | 2018 | 2210 | 0.430 |
Why?
|
Electrophysiological Phenomena | 1 | 2015 | 309 | 0.430 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 270 | 0.410 |
Why?
|
Sympathetic Nervous System | 22 | 2004 | 520 | 0.410 |
Why?
|
Coronary Artery Disease | 6 | 2021 | 6575 | 0.400 |
Why?
|
Epinephrine | 9 | 2016 | 782 | 0.400 |
Why?
|
Blood Pressure | 38 | 2015 | 8533 | 0.400 |
Why?
|
Models, Cardiovascular | 4 | 2013 | 978 | 0.400 |
Why?
|
Sleep | 9 | 2020 | 4814 | 0.400 |
Why?
|
Hemodynamics | 17 | 2016 | 4188 | 0.390 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2011 | 42 | 0.380 |
Why?
|
Female | 117 | 2024 | 396532 | 0.380 |
Why?
|
Recurrence | 1 | 2024 | 8507 | 0.380 |
Why?
|
Bradycardia | 1 | 2013 | 304 | 0.370 |
Why?
|
Cardiac Pacing, Artificial | 12 | 2009 | 881 | 0.370 |
Why?
|
Infusions, Intravenous | 4 | 2018 | 2228 | 0.360 |
Why?
|
Rest | 1 | 2015 | 940 | 0.350 |
Why?
|
Diabetes Mellitus | 3 | 2017 | 5888 | 0.350 |
Why?
|
Time Factors | 26 | 2024 | 40149 | 0.350 |
Why?
|
Middle Aged | 51 | 2024 | 223267 | 0.350 |
Why?
|
Calcium | 4 | 2017 | 5783 | 0.340 |
Why?
|
Atrial Flutter | 1 | 2012 | 253 | 0.340 |
Why?
|
Survival Analysis | 4 | 2013 | 10101 | 0.330 |
Why?
|
Tachycardia, Supraventricular | 1 | 2012 | 272 | 0.330 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2007 | 843 | 0.330 |
Why?
|
Microvessels | 1 | 2013 | 586 | 0.320 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2662 | 0.320 |
Why?
|
Drug Compounding | 2 | 2020 | 236 | 0.310 |
Why?
|
Circadian Rhythm | 5 | 2012 | 2590 | 0.310 |
Why?
|
Differential Threshold | 3 | 2008 | 80 | 0.310 |
Why?
|
Angina Pectoris | 2 | 2011 | 956 | 0.310 |
Why?
|
Calcium Channel Blockers | 5 | 2010 | 687 | 0.310 |
Why?
|
Brain Ischemia | 1 | 2022 | 3001 | 0.310 |
Why?
|
Catheters, Indwelling | 2 | 2007 | 436 | 0.290 |
Why?
|
Endothelium, Vascular | 2 | 2011 | 4424 | 0.290 |
Why?
|
Risk Factors | 31 | 2024 | 74889 | 0.290 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 1281 | 0.290 |
Why?
|
Nerve Growth Factor | 2 | 2005 | 156 | 0.290 |
Why?
|
Pericardial Effusion | 2 | 2000 | 246 | 0.280 |
Why?
|
Electric Stimulation | 23 | 2015 | 1736 | 0.280 |
Why?
|
Population Surveillance | 2 | 2015 | 2594 | 0.280 |
Why?
|
Exercise Therapy | 1 | 2014 | 935 | 0.280 |
Why?
|
Myocardial Reperfusion Injury | 3 | 1996 | 483 | 0.280 |
Why?
|
Prognosis | 19 | 2023 | 29959 | 0.280 |
Why?
|
Propanolamines | 4 | 2012 | 164 | 0.280 |
Why?
|
Foreign-Body Reaction | 1 | 2007 | 156 | 0.270 |
Why?
|
Coronary Vessels | 13 | 2011 | 3115 | 0.270 |
Why?
|
Atrioventricular Block | 3 | 2013 | 141 | 0.260 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 2005 | 63 | 0.260 |
Why?
|
Syndrome | 2 | 2023 | 3271 | 0.250 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10745 | 0.250 |
Why?
|
Finland | 7 | 2018 | 608 | 0.250 |
Why?
|
Diltiazem | 3 | 2013 | 132 | 0.250 |
Why?
|
Practice Guidelines as Topic | 3 | 2012 | 7430 | 0.250 |
Why?
|
Inhalation Exposure | 3 | 2008 | 432 | 0.240 |
Why?
|
Air Pollution | 6 | 2009 | 2377 | 0.240 |
Why?
|
Evidence-Based Medicine | 2 | 2016 | 3692 | 0.240 |
Why?
|
Cardiomyopathies | 1 | 2017 | 2058 | 0.240 |
Why?
|
Recovery of Function | 2 | 2014 | 2978 | 0.240 |
Why?
|
Coronary Angiography | 4 | 2021 | 4525 | 0.230 |
Why?
|
Patient Readmission | 1 | 2018 | 3283 | 0.220 |
Why?
|
Particle Size | 8 | 2005 | 1633 | 0.220 |
Why?
|
Injections | 6 | 2010 | 839 | 0.220 |
Why?
|
Aged | 33 | 2024 | 171344 | 0.220 |
Why?
|
Refractory Period, Electrophysiological | 5 | 2010 | 40 | 0.220 |
Why?
|
Parasympathectomy | 1 | 2002 | 3 | 0.210 |
Why?
|
Guinea Pigs | 2 | 2014 | 1309 | 0.210 |
Why?
|
Ion Channels | 3 | 2013 | 1043 | 0.210 |
Why?
|
Disease Susceptibility | 7 | 2016 | 1791 | 0.200 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2008 | 698 | 0.200 |
Why?
|
Acetylcholine | 4 | 2015 | 628 | 0.200 |
Why?
|
Sinoatrial Node | 1 | 2002 | 99 | 0.200 |
Why?
|
Survival Rate | 7 | 2018 | 12826 | 0.200 |
Why?
|
Pacemaker, Artificial | 5 | 2010 | 828 | 0.200 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3250 | 0.200 |
Why?
|
Random Allocation | 2 | 2018 | 2394 | 0.200 |
Why?
|
Carbon Monoxide | 6 | 2005 | 560 | 0.190 |
Why?
|
Reference Values | 4 | 2017 | 4914 | 0.190 |
Why?
|
Adult | 29 | 2023 | 223305 | 0.190 |
Why?
|
Follow-Up Studies | 12 | 2023 | 39312 | 0.190 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7870 | 0.180 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2023 | 1337 | 0.180 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2009 | 1457 | 0.180 |
Why?
|
Tachycardia | 4 | 2000 | 598 | 0.180 |
Why?
|
Japan | 3 | 2018 | 1418 | 0.170 |
Why?
|
Periodicity | 2 | 2002 | 347 | 0.170 |
Why?
|
Lung | 1 | 2018 | 10068 | 0.170 |
Why?
|
Insulin | 3 | 2013 | 6608 | 0.170 |
Why?
|
Glucosides | 1 | 2024 | 533 | 0.160 |
Why?
|
Drug Therapy, Combination | 4 | 2014 | 6306 | 0.160 |
Why?
|
Nebulizers and Vaporizers | 1 | 2020 | 138 | 0.160 |
Why?
|
Instillation, Drug | 1 | 2018 | 32 | 0.160 |
Why?
|
Blood Glucose | 1 | 2013 | 6422 | 0.160 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20146 | 0.160 |
Why?
|
Gadolinium DTPA | 1 | 2002 | 823 | 0.150 |
Why?
|
Vascular Resistance | 8 | 2011 | 939 | 0.150 |
Why?
|
Nerve Regeneration | 1 | 2004 | 796 | 0.150 |
Why?
|
Carbon | 5 | 2005 | 672 | 0.150 |
Why?
|
Verapamil | 3 | 1996 | 242 | 0.150 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4968 | 0.150 |
Why?
|
Paracentesis | 1 | 1998 | 99 | 0.150 |
Why?
|
Purines | 1 | 2021 | 615 | 0.150 |
Why?
|
Electrophysiology | 9 | 2005 | 1263 | 0.150 |
Why?
|
Incidence | 6 | 2020 | 21527 | 0.150 |
Why?
|
Dobutamine | 2 | 2011 | 114 | 0.150 |
Why?
|
Clonidine | 3 | 1989 | 170 | 0.140 |
Why?
|
Cardiac Tamponade | 1 | 1998 | 175 | 0.140 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 944 | 0.140 |
Why?
|
Injections, Intravenous | 4 | 2014 | 1377 | 0.140 |
Why?
|
Electrodes | 3 | 2017 | 612 | 0.140 |
Why?
|
Hypertension, Pulmonary | 2 | 2012 | 1604 | 0.130 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3723 | 0.130 |
Why?
|
Ventricular Premature Complexes | 2 | 2016 | 112 | 0.130 |
Why?
|
Chronic Disease | 2 | 2023 | 9358 | 0.130 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 357 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2024 | 12246 | 0.130 |
Why?
|
Telemetry | 1 | 2017 | 201 | 0.130 |
Why?
|
Serotonin Antagonists | 1 | 1996 | 146 | 0.130 |
Why?
|
Case-Control Studies | 3 | 2024 | 22248 | 0.130 |
Why?
|
Fentanyl | 2 | 1989 | 451 | 0.120 |
Why?
|
Specimen Handling | 1 | 2000 | 706 | 0.120 |
Why?
|
Myocardium | 5 | 2007 | 4765 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2014 | 6214 | 0.120 |
Why?
|
Cardiotonic Agents | 2 | 2023 | 541 | 0.120 |
Why?
|
Pulse Therapy, Drug | 1 | 2014 | 37 | 0.120 |
Why?
|
Stress, Physiological | 2 | 2000 | 1407 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 1999 | 988 | 0.120 |
Why?
|
Dreams | 1 | 1996 | 145 | 0.120 |
Why?
|
Vagotomy | 13 | 1995 | 82 | 0.120 |
Why?
|
Prazosin | 2 | 2011 | 95 | 0.120 |
Why?
|
Parasympathetic Nervous System | 8 | 2004 | 144 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2016 | 1790 | 0.110 |
Why?
|
Tachycardia, Sinus | 1 | 1993 | 43 | 0.110 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2013 | 39 | 0.110 |
Why?
|
Isoproterenol | 2 | 2013 | 398 | 0.110 |
Why?
|
Biophysics | 1 | 2014 | 376 | 0.110 |
Why?
|
Trauma Centers | 1 | 1999 | 950 | 0.110 |
Why?
|
Child | 7 | 2019 | 80670 | 0.100 |
Why?
|
Ischemia | 1 | 2022 | 1905 | 0.100 |
Why?
|
Electroencephalography | 5 | 2022 | 6282 | 0.100 |
Why?
|
Adaptation, Physiological | 2 | 2010 | 1312 | 0.100 |
Why?
|
Cross-Over Studies | 2 | 2017 | 2105 | 0.100 |
Why?
|
Pulmonary Artery | 1 | 2001 | 1938 | 0.100 |
Why?
|
Operating Rooms | 1 | 1999 | 790 | 0.100 |
Why?
|
Particulate Matter | 4 | 2008 | 2621 | 0.100 |
Why?
|
Exercise | 4 | 2014 | 5945 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14653 | 0.100 |
Why?
|
Trachea | 1 | 2018 | 1094 | 0.100 |
Why?
|
Causality | 2 | 2013 | 1252 | 0.100 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2011 | 18 | 0.100 |
Why?
|
Pressoreceptors | 5 | 2004 | 98 | 0.100 |
Why?
|
Cats | 8 | 2000 | 972 | 0.100 |
Why?
|
Natriuretic Agents | 1 | 2011 | 57 | 0.100 |
Why?
|
Doxorubicin | 1 | 2018 | 2229 | 0.090 |
Why?
|
Patient Selection | 2 | 2016 | 4252 | 0.090 |
Why?
|
Anesthesia, General | 1 | 2018 | 1188 | 0.090 |
Why?
|
Ultrasonography, Interventional | 2 | 1999 | 1521 | 0.090 |
Why?
|
Cardiac Complexes, Premature | 13 | 2004 | 63 | 0.090 |
Why?
|
Health Surveys | 3 | 2018 | 4055 | 0.090 |
Why?
|
Pyrazoles | 1 | 2021 | 2030 | 0.090 |
Why?
|
Gene Transfer Techniques | 2 | 2013 | 1206 | 0.090 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2011 | 168 | 0.090 |
Why?
|
Luminescent Agents | 1 | 2010 | 29 | 0.090 |
Why?
|
Artifacts | 1 | 2019 | 1897 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 962 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2002 | 3317 | 0.090 |
Why?
|
Vehicle Emissions | 2 | 2005 | 651 | 0.090 |
Why?
|
Models, Animal | 3 | 2012 | 2121 | 0.090 |
Why?
|
Carbazoles | 1 | 2012 | 230 | 0.090 |
Why?
|
Algorithms | 5 | 2008 | 14073 | 0.090 |
Why?
|
Sulfur Dioxide | 3 | 2005 | 178 | 0.090 |
Why?
|
Fluoroscopy | 1 | 2014 | 948 | 0.090 |
Why?
|
Disasters | 1 | 1996 | 521 | 0.080 |
Why?
|
Adenoviridae | 2 | 2012 | 1093 | 0.080 |
Why?
|
Aspirin | 1 | 2001 | 3134 | 0.080 |
Why?
|
Cicatrix | 1 | 2016 | 798 | 0.080 |
Why?
|
Placebos | 1 | 2014 | 1659 | 0.080 |
Why?
|
Silicones | 2 | 2007 | 228 | 0.080 |
Why?
|
Risk | 3 | 2018 | 9602 | 0.080 |
Why?
|
Behavior | 1 | 1992 | 538 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1794 | 0.080 |
Why?
|
Receptors, Opioid | 1 | 1989 | 145 | 0.080 |
Why?
|
Constriction | 5 | 1993 | 168 | 0.080 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2023 | 0.080 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1529 | 0.080 |
Why?
|
Femoral Artery | 3 | 2011 | 827 | 0.080 |
Why?
|
Young Adult | 5 | 2019 | 59939 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2011 | 1478 | 0.080 |
Why?
|
Contrast Media | 1 | 2002 | 5329 | 0.080 |
Why?
|
Cause of Death | 3 | 2018 | 3717 | 0.080 |
Why?
|
Magnesium | 1 | 2012 | 815 | 0.080 |
Why?
|
Muscle Proteins | 2 | 2013 | 1160 | 0.080 |
Why?
|
Sodium | 2 | 2012 | 1594 | 0.070 |
Why?
|
Adolescent | 5 | 2019 | 88902 | 0.070 |
Why?
|
Heart Failure, Systolic | 1 | 2009 | 134 | 0.070 |
Why?
|
Prevalence | 4 | 2016 | 15835 | 0.070 |
Why?
|
Glycopyrrolate | 2 | 1998 | 35 | 0.070 |
Why?
|
Nitrogen Dioxide | 3 | 2005 | 535 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2021 | 59548 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10619 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2007 | 192 | 0.070 |
Why?
|
Ganglia | 1 | 2006 | 86 | 0.070 |
Why?
|
Cardiac Glycosides | 1 | 1986 | 29 | 0.070 |
Why?
|
Hippocampus | 1 | 1999 | 3776 | 0.070 |
Why?
|
Postoperative Complications | 3 | 2021 | 15831 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15912 | 0.070 |
Why?
|
Comorbidity | 2 | 2013 | 10580 | 0.070 |
Why?
|
Muscarinic Antagonists | 2 | 1998 | 135 | 0.070 |
Why?
|
Naloxone | 1 | 1989 | 372 | 0.060 |
Why?
|
Equipment Design | 2 | 2007 | 3488 | 0.060 |
Why?
|
Receptors, Muscarinic | 4 | 1995 | 156 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2009 | 1721 | 0.060 |
Why?
|
Morphine | 3 | 1986 | 658 | 0.060 |
Why?
|
Intensive Care Units | 1 | 1999 | 3799 | 0.060 |
Why?
|
Child, Preschool | 2 | 2019 | 42577 | 0.060 |
Why?
|
Prospective Studies | 5 | 2019 | 54872 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2021 | 3421 | 0.060 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2010 | 856 | 0.060 |
Why?
|
Infusion Pumps, Implantable | 1 | 2005 | 158 | 0.060 |
Why?
|
Drug Design | 1 | 2010 | 1043 | 0.060 |
Why?
|
Sudden Infant Death | 1 | 1988 | 293 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2062 | 0.060 |
Why?
|
Kinetics | 3 | 2013 | 6288 | 0.060 |
Why?
|
Sulfates | 2 | 2005 | 379 | 0.060 |
Why?
|
GAP-43 Protein | 1 | 2004 | 152 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1733 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2024 | 81657 | 0.060 |
Why?
|
Air Pollutants, Occupational | 1 | 2006 | 406 | 0.060 |
Why?
|
Automobile Driving | 1 | 2009 | 442 | 0.060 |
Why?
|
Norepinephrine | 11 | 1987 | 898 | 0.060 |
Why?
|
Heart Block | 1 | 2005 | 391 | 0.060 |
Why?
|
Control Groups | 1 | 2004 | 107 | 0.060 |
Why?
|
Societies, Medical | 2 | 2017 | 3957 | 0.060 |
Why?
|
Respiration | 2 | 2000 | 1654 | 0.050 |
Why?
|
Hospitalization | 2 | 2022 | 10816 | 0.050 |
Why?
|
Nitric Oxide Donors | 1 | 2003 | 123 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2017 | 12430 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1750 | 0.050 |
Why?
|
Potassium | 7 | 1987 | 1314 | 0.050 |
Why?
|
Environmental Exposure | 5 | 2005 | 4544 | 0.050 |
Why?
|
Aorta | 3 | 2006 | 2043 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.050 |
Why?
|
Mesenteric Arteries | 3 | 1971 | 177 | 0.050 |
Why?
|
Adrenal Glands | 5 | 1975 | 556 | 0.050 |
Why?
|
Neural Pathways | 1 | 2013 | 3079 | 0.050 |
Why?
|
Buprenorphine | 1 | 1989 | 667 | 0.050 |
Why?
|
Myocardial Reperfusion | 2 | 2011 | 338 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13476 | 0.050 |
Why?
|
Atropine | 7 | 1988 | 243 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 189 | 0.050 |
Why?
|
Models, Biological | 5 | 2008 | 9464 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6548 | 0.050 |
Why?
|
Receptors, Adrenergic | 4 | 1986 | 155 | 0.040 |
Why?
|
Ozone | 2 | 2005 | 497 | 0.040 |
Why?
|
Heart Septum | 1 | 2002 | 304 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18397 | 0.040 |
Why?
|
Infant | 3 | 2019 | 36459 | 0.040 |
Why?
|
Diuretics | 1 | 2023 | 614 | 0.040 |
Why?
|
Ergometry | 2 | 2010 | 17 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2001 | 297 | 0.040 |
Why?
|
Neural Conduction | 2 | 1978 | 442 | 0.040 |
Why?
|
Psychophysiology | 1 | 2000 | 136 | 0.040 |
Why?
|
Heart Function Tests | 3 | 1996 | 315 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 41706 | 0.040 |
Why?
|
Proportional Hazards Models | 5 | 2014 | 12536 | 0.040 |
Why?
|
Multivariate Analysis | 4 | 2010 | 12064 | 0.040 |
Why?
|
Equipment Safety | 1 | 2000 | 250 | 0.040 |
Why?
|
Punctures | 1 | 2000 | 371 | 0.040 |
Why?
|
Ultrasonography | 1 | 2012 | 5990 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6853 | 0.040 |
Why?
|
Platelet Aggregation | 4 | 1986 | 769 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2505 | 0.040 |
Why?
|
Atenolol | 1 | 1998 | 99 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2002 | 2275 | 0.040 |
Why?
|
Hemorrhage | 3 | 2000 | 3464 | 0.040 |
Why?
|
Membranes | 1 | 1997 | 164 | 0.030 |
Why?
|
Nifedipine | 2 | 1988 | 220 | 0.030 |
Why?
|
Vasomotor System | 2 | 1985 | 208 | 0.030 |
Why?
|
Laparotomy | 1 | 1999 | 459 | 0.030 |
Why?
|
Europe | 1 | 2003 | 3430 | 0.030 |
Why?
|
Gastrostomy | 1 | 1999 | 325 | 0.030 |
Why?
|
Nervous System | 2 | 1977 | 542 | 0.030 |
Why?
|
Atrial Appendage | 1 | 2000 | 285 | 0.030 |
Why?
|
Occupational Exposure | 1 | 2006 | 1807 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5306 | 0.030 |
Why?
|
Muscle Contraction | 2 | 1971 | 1208 | 0.030 |
Why?
|
Precipitating Factors | 1 | 1996 | 51 | 0.030 |
Why?
|
Ions | 1 | 1997 | 254 | 0.030 |
Why?
|
Disease Progression | 2 | 2011 | 13642 | 0.030 |
Why?
|
Serotonin | 3 | 1987 | 1045 | 0.030 |
Why?
|
Acute Disease | 3 | 2004 | 7240 | 0.030 |
Why?
|
Tobacco Smoke Pollution | 1 | 2001 | 828 | 0.030 |
Why?
|
Tracheostomy | 1 | 1999 | 430 | 0.030 |
Why?
|
Wakefulness | 2 | 1995 | 1282 | 0.030 |
Why?
|
Angina Pectoris, Variant | 1 | 1994 | 52 | 0.030 |
Why?
|
Cardiovascular System | 2 | 1992 | 839 | 0.030 |
Why?
|
Receptors, Adrenergic, alpha | 2 | 1985 | 146 | 0.030 |
Why?
|
Affect | 1 | 2021 | 1494 | 0.030 |
Why?
|
Hypothalamus | 2 | 1976 | 1003 | 0.030 |
Why?
|
Microcomputers | 1 | 1993 | 139 | 0.030 |
Why?
|
Fear | 2 | 1992 | 1496 | 0.030 |
Why?
|
Lymphocytes | 1 | 2000 | 2606 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2936 | 0.030 |
Why?
|
Adrenalectomy | 6 | 1975 | 347 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8045 | 0.020 |
Why?
|
Biological Transport | 1 | 1997 | 2083 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 10384 | 0.020 |
Why?
|
Fourier Analysis | 1 | 1993 | 434 | 0.020 |
Why?
|
Psychotherapy | 1 | 2021 | 1648 | 0.020 |
Why?
|
Linear Models | 2 | 2014 | 5873 | 0.020 |
Why?
|
Potassium Channel Blockers | 1 | 2012 | 162 | 0.020 |
Why?
|
Denervation | 6 | 1983 | 265 | 0.020 |
Why?
|
Phenylephrine | 4 | 1983 | 292 | 0.020 |
Why?
|
Internationality | 1 | 2017 | 1006 | 0.020 |
Why?
|
Angioplasty | 1 | 1994 | 355 | 0.020 |
Why?
|
Perfusion | 4 | 1986 | 1409 | 0.020 |
Why?
|
Image Enhancement | 1 | 2002 | 2858 | 0.020 |
Why?
|
Ventricular Function | 3 | 1978 | 403 | 0.020 |
Why?
|
Adrenal Insufficiency | 2 | 1970 | 194 | 0.020 |
Why?
|
Posture | 1 | 1995 | 955 | 0.020 |
Why?
|
Polysomnography | 2 | 2000 | 1868 | 0.020 |
Why?
|
Physical Conditioning, Animal | 1 | 1994 | 363 | 0.020 |
Why?
|
Atropine Derivatives | 2 | 1988 | 5 | 0.020 |
Why?
|
Reperfusion | 1 | 1991 | 268 | 0.020 |
Why?
|
Mathematics | 1 | 1991 | 696 | 0.020 |
Why?
|
Ganglionectomy | 1 | 1989 | 11 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1940 | 0.020 |
Why?
|
Synaptic Transmission | 2 | 1987 | 1175 | 0.020 |
Why?
|
Behavior, Animal | 2 | 1987 | 1865 | 0.020 |
Why?
|
Propranolol | 7 | 1983 | 493 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5038 | 0.020 |
Why?
|
Coloring Agents | 1 | 1971 | 565 | 0.020 |
Why?
|
Environmental Monitoring | 2 | 2005 | 1467 | 0.020 |
Why?
|
Peripheral Nerves | 2 | 1984 | 490 | 0.020 |
Why?
|
Receptors, Opioid, mu | 1 | 1989 | 167 | 0.020 |
Why?
|
Ganglia, Sympathetic | 1 | 1988 | 65 | 0.020 |
Why?
|
Reoperation | 1 | 1999 | 4325 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3431 | 0.020 |
Why?
|
Blood Vessels | 2 | 1971 | 1111 | 0.020 |
Why?
|
Central Nervous System | 2 | 1987 | 1345 | 0.020 |
Why?
|
Blood Volume | 1 | 1969 | 544 | 0.020 |
Why?
|
Computer Simulation | 1 | 2002 | 6258 | 0.020 |
Why?
|
Phenelzine | 1 | 1987 | 28 | 0.020 |
Why?
|
Parasympatholytics | 1 | 1988 | 89 | 0.020 |
Why?
|
Shock | 1 | 1970 | 316 | 0.020 |
Why?
|
5-Hydroxytryptophan | 1 | 1987 | 33 | 0.020 |
Why?
|
Carbidopa | 1 | 1987 | 30 | 0.020 |
Why?
|
Bicycling | 1 | 2009 | 177 | 0.020 |
Why?
|
Neutrophils | 1 | 2000 | 3782 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 1987 | 92 | 0.020 |
Why?
|
Consciousness | 3 | 1990 | 602 | 0.020 |
Why?
|
Epoprostenol | 3 | 1983 | 246 | 0.020 |
Why?
|
Hypokalemia | 2 | 1986 | 152 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 3208 | 0.020 |
Why?
|
Desoxycorticosterone | 1 | 1966 | 46 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 1987 | 224 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 1971 | 930 | 0.020 |
Why?
|
Muscles | 1 | 1971 | 1576 | 0.020 |
Why?
|
Welding | 1 | 2006 | 89 | 0.020 |
Why?
|
Critical Illness | 1 | 1999 | 2750 | 0.020 |
Why?
|
Odds Ratio | 2 | 2013 | 9661 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1999 | 5536 | 0.020 |
Why?
|
ROC Curve | 1 | 2013 | 3621 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 1987 | 345 | 0.020 |
Why?
|
Propylamines | 1 | 1986 | 161 | 0.020 |
Why?
|
Vasoconstriction | 1 | 1988 | 591 | 0.020 |
Why?
|
Microspheres | 1 | 2008 | 774 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13276 | 0.020 |
Why?
|
Research | 1 | 1993 | 1977 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2009 | 893 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 1994 | 2189 | 0.010 |
Why?
|
Vascular Patency | 1 | 1988 | 915 | 0.010 |
Why?
|
Thoracotomy | 1 | 2006 | 374 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 1985 | 171 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2010 | 968 | 0.010 |
Why?
|
Conditioning, Classical | 1 | 1987 | 368 | 0.010 |
Why?
|
United States | 2 | 2003 | 72945 | 0.010 |
Why?
|
Nucleotides, Cyclic | 1 | 1985 | 83 | 0.010 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1985 | 243 | 0.010 |
Why?
|
Angiotensin II | 1 | 1966 | 843 | 0.010 |
Why?
|
Methoxamine | 1 | 1983 | 45 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 1993 | 2671 | 0.010 |
Why?
|
Sulfinpyrazone | 1 | 1982 | 15 | 0.010 |
Why?
|
Reflex | 1 | 1985 | 375 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1986 | 951 | 0.010 |
Why?
|
Dust | 1 | 2005 | 488 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 1986 | 661 | 0.010 |
Why?
|
Social Environment | 1 | 1987 | 1012 | 0.010 |
Why?
|
Rats | 4 | 2004 | 23717 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8108 | 0.010 |
Why?
|
Carotid Sinus | 3 | 1979 | 44 | 0.010 |
Why?
|
Air Pollution, Indoor | 1 | 2009 | 931 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36570 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1970 | 1884 | 0.010 |
Why?
|
Sympathomimetics | 1 | 1981 | 56 | 0.010 |
Why?
|
Muscle Tonus | 2 | 1971 | 82 | 0.010 |
Why?
|
Prostaglandins | 1 | 1982 | 398 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 23618 | 0.010 |
Why?
|
Bronchoalveolar Lavage | 1 | 2000 | 131 | 0.010 |
Why?
|
Electrooculography | 1 | 2000 | 112 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6329 | 0.010 |
Why?
|
Postoperative Care | 1 | 2006 | 1480 | 0.010 |
Why?
|
Shock, Surgical | 2 | 1970 | 10 | 0.010 |
Why?
|
Dexamethasone | 2 | 1968 | 1962 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5454 | 0.010 |
Why?
|
Digitalis Glycosides | 1 | 1979 | 47 | 0.010 |
Why?
|
Utah | 1 | 1999 | 130 | 0.010 |
Why?
|
Prenylamine | 1 | 1979 | 1 | 0.010 |
Why?
|
Reserpine | 2 | 1981 | 63 | 0.010 |
Why?
|
Massachusetts | 2 | 2005 | 8890 | 0.010 |
Why?
|
Cell Membrane Permeability | 2 | 1971 | 568 | 0.010 |
Why?
|
Bronchitis | 1 | 2000 | 193 | 0.010 |
Why?
|
Software | 1 | 1993 | 4464 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8065 | 0.010 |
Why?
|
Glucose | 2 | 1981 | 4340 | 0.010 |
Why?
|
Brain | 3 | 2000 | 27158 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 26309 | 0.010 |
Why?
|
Electromyography | 1 | 2000 | 1398 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2010 | 12985 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
Pulse | 1 | 1974 | 217 | 0.010 |
Why?
|
Calcium Chloride | 2 | 1971 | 78 | 0.010 |
Why?
|
Seasons | 1 | 1999 | 1519 | 0.010 |
Why?
|
Cardiology | 1 | 1984 | 1701 | 0.010 |
Why?
|
Blood Circulation | 2 | 1969 | 248 | 0.010 |
Why?
|
Potassium Chloride | 1 | 1971 | 228 | 0.010 |
Why?
|
Serum Albumin, Radio-Iodinated | 1 | 1969 | 37 | 0.010 |
Why?
|
Venoms | 1 | 1970 | 94 | 0.010 |
Why?
|
Practolol | 2 | 1982 | 3 | 0.010 |
Why?
|
Rheology | 1 | 1971 | 347 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3343 | 0.000 |
Why?
|
Shock, Hemorrhagic | 1 | 1970 | 224 | 0.000 |
Why?
|
Infusions, Parenteral | 2 | 1979 | 395 | 0.000 |
Why?
|
Hematocrit | 1 | 1969 | 622 | 0.000 |
Why?
|
Cardiac Output | 2 | 1968 | 837 | 0.000 |
Why?
|
Blood | 1 | 1971 | 598 | 0.000 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 1987 | 60 | 0.000 |
Why?
|
Methoxyhydroxyphenylglycol | 1 | 1987 | 93 | 0.000 |
Why?
|
Pressure | 1 | 1971 | 1172 | 0.000 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1987 | 94 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1974 | 1110 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1988 | 26387 | 0.000 |
Why?
|
Methacholine Compounds | 1 | 1986 | 35 | 0.000 |
Why?
|
Hindlimb | 1 | 1969 | 513 | 0.000 |
Why?
|
Stimulation, Chemical | 2 | 1978 | 305 | 0.000 |
Why?
|
Methacholine Chloride | 1 | 1986 | 219 | 0.000 |
Why?
|
Lidocaine | 2 | 1982 | 545 | 0.000 |
Why?
|
Caffeine | 1 | 1971 | 702 | 0.000 |
Why?
|
Albuterol | 1 | 1987 | 211 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1971 | 2001 | 0.000 |
Why?
|
Temperature | 1 | 1971 | 2231 | 0.000 |
Why?
|
Shock, Septic | 1 | 1970 | 772 | 0.000 |
Why?
|
Oxprenolol | 1 | 1983 | 1 | 0.000 |
Why?
|
Pindolol | 1 | 1983 | 34 | 0.000 |
Why?
|
Prostaglandins E | 1 | 1983 | 166 | 0.000 |
Why?
|
Alprostadil | 1 | 1983 | 86 | 0.000 |
Why?
|
Ergonovine | 1 | 1982 | 14 | 0.000 |
Why?
|
Indomethacin | 1 | 1983 | 323 | 0.000 |
Why?
|
Drug Synergism | 1 | 1966 | 1757 | 0.000 |
Why?
|
Systole | 1 | 1983 | 935 | 0.000 |
Why?
|
Adrenergic Fibers | 1 | 1980 | 21 | 0.000 |
Why?
|
Solutions | 1 | 1981 | 405 | 0.000 |
Why?
|
Strophanthidin | 1 | 1979 | 15 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1983 | 1374 | 0.000 |
Why?
|
Ouabain | 1 | 1979 | 246 | 0.000 |
Why?
|
Protein Binding | 1 | 1971 | 9326 | 0.000 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 742 | 0.000 |
Why?
|
Methods | 1 | 1979 | 1065 | 0.000 |
Why?
|
Electrolytes | 1 | 1979 | 279 | 0.000 |
Why?
|
Cisterna Magna | 1 | 1978 | 39 | 0.000 |
Why?
|
Sympathectomy | 1 | 1977 | 72 | 0.000 |
Why?
|
Physical Stimulation | 1 | 1978 | 514 | 0.000 |
Why?
|
Phentolamine | 1 | 1976 | 102 | 0.000 |
Why?
|
Parasympathomimetics | 1 | 1976 | 28 | 0.000 |
Why?
|
Ligation | 1 | 1977 | 446 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1978 | 1622 | 0.000 |
Why?
|
Electroshock | 1 | 1973 | 120 | 0.000 |
Why?
|
Oxygen | 1 | 1983 | 4252 | 0.000 |
Why?
|
Buffers | 1 | 1971 | 141 | 0.000 |
Why?
|
Mineralocorticoids | 1 | 1968 | 37 | 0.000 |
Why?
|
Transducers | 1 | 1968 | 238 | 0.000 |
Why?
|
Dextrans | 1 | 1968 | 574 | 0.000 |
Why?
|
Aldosterone | 1 | 1968 | 881 | 0.000 |
Why?
|
Hypotension | 1 | 1968 | 887 | 0.000 |
Why?
|
Hydrocortisone | 1 | 1968 | 1838 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1968 | 2158 | 0.000 |
Why?
|